DC Investment Partners

Verana Networks, Inc. is a technology company based in Waltham, Massachusetts, founded in 2019. It specializes in developing innovative 5G Radio Access Network solutions tailored for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company’s focus on mmWave spectrum is strategic, as it represents a significant portion of new spectrum available for 5G services. Verana Networks aims to empower mobile network operators with equipment that enhances wireless connectivity, providing a substantial increase in speed and capacity essential for the success of 5G technology. This advancement not only facilitates new applications but also generates additional revenue opportunities, which are crucial for sustaining the business case for 5G deployment.

Kandou Bus SA is a Swiss company focused on designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Kandou specializes in creating serial links that enhance data transfer speeds while minimizing power consumption across various applications, including DRAM, graphics cards, server backplanes, mobile devices, game consoles, routers, and FPGAs. The company's innovative approach allows for increased bit rates and extended reach in physical communications, enabling more efficient data transmission. By reducing energy requirements, Kandou's technology supports longer battery life and smaller device footprints, making it a vital player in the evolving landscape of electronics. The team comprises skilled scientists and engineers operating in Switzerland, the UK, and the US, dedicated to advancing the capabilities of serial link design.

Werewolf Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative receptor agonists for cancer immunotherapy. Founded in 2017, the company is dedicated to creating therapeutics that stimulate the body’s immune system to combat cancer. Utilizing its proprietary PREDATOR platform, Werewolf designs conditionally activated molecules known as INDUKINE, which are engineered to remain inactive in peripheral tissues while selectively activating within the tumor microenvironment. This approach aims to overcome the limitations of traditional proinflammatory immune therapies, enhancing both adaptive and innate immunity to improve cancer treatment outcomes.

Verana Networks, Inc. is a technology company based in Waltham, Massachusetts, founded in 2019. It specializes in developing innovative 5G Radio Access Network solutions tailored for service providers utilizing licensed millimeter wave (mmWave) spectrum. The company’s focus on mmWave spectrum is strategic, as it represents a significant portion of new spectrum available for 5G services. Verana Networks aims to empower mobile network operators with equipment that enhances wireless connectivity, providing a substantial increase in speed and capacity essential for the success of 5G technology. This advancement not only facilitates new applications but also generates additional revenue opportunities, which are crucial for sustaining the business case for 5G deployment.